New antifungal drug aims to beat deadly mould infections
NCT ID NCT07215273
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 34 times
Summary
This study tests a new medicine called EL219 against the usual treatment for early suspected invasive mould infections. About 80 adults at high risk, such as bone marrow transplant recipients, will take part. The goal is to see if EL219 is safer and more effective at reducing deaths and serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUSPECTED INVASIVE MOULD INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
U. of Texas, MD Anderson
RECRUITINGHouston, Texas, 77030, United States
-
Washington U.
RECRUITINGSt Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.